A Double-Blind Placebo Controlled Therapeutic Trial on Patients with Stable Non-Segmental Vitiligo Using a Specially Formulated Reducing Antioxidant Gel Enhanced by Excimer Light Exposure

Background: Vitiligo is a common skin condition that causes patches of lightening that affect 0.2 to 0.5 percent of the world's population. It is marked by chalky white macules because melanocytes are being selectively lost. Several ideas have been put forward about what causes the disease, suc...

Full description

Bibliographic Details
Main Authors: Abdallah Hassan, Shaker Ezzeddin, Emad Elrewiny
Format: Article
Language:English
Published: Al-Azhar University, Faculty of Medicine (Damietta) 2023-09-01
Series:International Journal of Medical Arts
Subjects:
Online Access:https://ijma.journals.ekb.eg/article_326663_9bf715912fffadabc38b1b1604d11cac.pdf

Similar Items